Search Results

Displaying Results 1-14 of 14 "'EXAS'"

Jun 25, 2026, 18:00 ET Select Water Solutions Announces Definitive Agreement with ISE Chemicals Corporation Providing for the Development of Commercial Iodine Production Facilities Utilizing Produced Water Infrastructure Across Texas, New Mexico and Oklahoma

oration-providing-for-the-development-of-commercial-iodine-production-facilities-utilizing-produced-water-infrastructure-across-texas-new-mexico-and-okl-302811278.htmlSOURCE Select Water Solutions, Inc.

More news about: Select Water Solutions, Inc.


Mar 16, 2026, 16:35 ET Everpure Simplifies Enterprise AI with Evergreen//One for AI and Data Stream Beta

NVIDIA STX reference architecture to support the next generation of AI factories powered by the Vera Rubin platform. By combining EXA's performance and scalability with STX components such as BlueField-enabled storage controllers and context memory architectures, Everpure optimizes the

More news about: Everpure


Feb 02, 2026, 15:30 ET $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger--JHG, FOLD, RAPT, and EXAS

EXAS) related to its sale to Abbott Laboratories. Under the terms of the proposed transaction, Exact Sciences shareholders are expected to receive

More news about: Monteverde & Associates PC


Jan 21, 2026, 15:58 ET $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS

EXAS) related to its sale to Abbott Laboratories. Under the terms of the proposed transaction, Exact Sciences shareholders are expected to receive $105.00

More news about: Monteverde & Associates PC


Jan 16, 2026, 14:02 ET Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

Exact Sciences Corporation (NasdaqCM: EXAS) to Abbott Laboratories (NYSE: ABT). Under the terms of the proposed transaction, shareholders of Exact Sciences will receive $105.00 in cash for each

More news about: Kahn Swick & Foti, LLC


Jan 08, 2026, 12:48 ET Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their Rights

multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-frge-exas-civi-kvue-shareholders-to-contact-the-firm-to-discuss-their-rights-302656546.htmlSOURCE

More news about: Halper Sadeh LLP


Jan 06, 2026, 11:00 ET Halper Sadeh LLC Encourages EXAS, SOAR, BTBD Shareholders to Contact the Firm to Discuss Their Rights

multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-exas-soar-btbd-shareholders-to-contact-the-firm-to-discuss-their-rights-302653831.htmlSOURCE

More news about: Halper Sadeh LLP


Dec 31, 2025, 07:25 ET Smart Oncology: 5 Stocks Chasing the $317B Prize

precision and therapeutic targeting defines the investment thesis for Oncolytics Biotech Inc. (NASDAQ: ONCY), Exact Sciences Corp. (NASDAQ: EXAS), Veracyte, Inc. (NASDAQ: VCYT), Hologic, Inc. (NASDAQ: HOLX), and Personalis, Inc. (NASDAQ: PSNL). 

More news about: USA News Group


Nov 28, 2025, 12:41 ET Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights

multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-semr-exas-mrsn-shareholders-to-contact-the-firm-to-discuss-their-rights-302628094.htmlSOURCE

More news about: Halper Sadeh LLP


Nov 27, 2025, 23:11 ET HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN

EXAS) related to its sale to Abbott Laboratories. Under the terms of the proposed transaction, Exact Sciences shareholders are expected to receive $105.00

More news about: Monteverde & Associates PC


Nov 25, 2025, 01:33 ET Halper Sadeh LLC Encourages GDOT, BLFY, EXAS Shareholders to Contact the Firm to Discuss Their Rights

multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-gdot-blfy-exas-shareholders-to-contact-the-firm-to-discuss-their-rights-302625177.htmlSOURCE

More news about: Halper Sadeh LLP


Nov 20, 2025, 19:50 ET Halper Sadeh LLC Encourages CIVI, JAMF, EXAS Shareholders to Contact the Firm to Discuss Their Rights

multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-civi-jamf-exas-shareholders-to-contact-the-firm-to-discuss-their-rights-302622476.htmlSOURCE

More news about: Halper Sadeh LLP


Nov 20, 2025, 11:45 ET Shareholder Alert: The Ademi Firm investigates whether Exact Sciences Corporation is obtaining a Fair Price for its Public Shareholders

MILWAUKEE, Nov. 20, 2025 /PRNewswire/ -- The Ademi Firm is investigating Exact Sciences (NASDAQ: EXAS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Abbott.

More news about: Ademi LLP


Nov 20, 2025, 07:30 ET Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

PARK, Ill., and MADISON, Wis., Nov. 20, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) and Exact Sciences (NASDAQ: EXAS) today announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics

More news about: Abbott


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.